Global Daunorubicin Sales Market Report 2024

Report ID: 883976 | Published Date: May 2024 | No. of Page: 145 | Base Year: 2023 | Rating: 4.8 | Webstory: Check our Web story
1 Daunorubicin Market Overview
    1.1 Daunorubicin Product Scope
    1.2 Daunorubicin Segment by Type
        1.2.1 Global Daunorubicin Sales by Type (2016 & 2021 & 2027)
        1.2.2 Intravenous
        1.2.3 Drip
    1.3 Daunorubicin Segment by Application
        1.3.1 Global Daunorubicin Sales Comparison by Application (2016 & 2021 & 2027)
        1.3.2 Acute Granulocyte
        1.3.3 Acute Lymphocyte Leukemia
    1.4 Daunorubicin Market Estimates and Forecasts (2016-2027)
        1.4.1 Global Daunorubicin Market Size in Value Growth Rate (2016-2027)
        1.4.2 Global Daunorubicin Market Size in Volume Growth Rate (2016-2027)
        1.4.3 Global Daunorubicin Price Trends (2016-2027)

2 Daunorubicin Estimates and Forecasts by Region
    2.1 Global Daunorubicin Market Size by Region: 2016 VS 2021 VS 2027
    2.2 Global Daunorubicin Retrospective Market Scenario by Region (2016-2021)
        2.2.1 Global Daunorubicin Sales Market Share by Region (2016-2021)
        2.2.2 Global Daunorubicin Revenue Market Share by Region (2016-2021)
    2.3 Global Daunorubicin Market Estimates and Forecasts by Region (2022-2027)
        2.3.1 Global Daunorubicin Sales Estimates and Forecasts by Region (2022-2027)
        2.3.2 Global Daunorubicin Revenue Forecast by Region (2022-2027)
    2.4 Geographic Market Analysis: Market Facts & Figures
        2.4.1 North America Daunorubicin Estimates and Projections (2016-2027)
        2.4.2 Europe Daunorubicin Estimates and Projections (2016-2027)
        2.4.3 China Daunorubicin Estimates and Projections (2016-2027)
        2.4.4 Japan Daunorubicin Estimates and Projections (2016-2027)
        2.4.5 Southeast Asia Daunorubicin Estimates and Projections (2016-2027)
        2.4.6 India Daunorubicin Estimates and Projections (2016-2027)
3 Global Daunorubicin Competition Landscape by Players
    3.1 Global Top Daunorubicin Players by Sales (2016-2021)
    3.2 Global Top Daunorubicin Players by Revenue (2016-2021)
    3.3 Global Daunorubicin Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Daunorubicin as of 2020)
    3.4 Global Daunorubicin Average Price by Company (2016-2021)
    3.5 Manufacturers Daunorubicin Manufacturing Sites, Area Served, Product Type
    3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Daunorubicin Market Size by Type
    4.1 Global Daunorubicin Historic Market Review by Type (2016-2021)
        4.1.1 Global Daunorubicin Sales Market Share by Type (2016-2021)
        4.1.2 Global Daunorubicin Revenue Market Share by Type (2016-2021)
        4.1.3 Global Daunorubicin Price by Type (2016-2021)
    4.2 Global Daunorubicin Market Estimates and Forecasts by Type (2022-2027)
        4.2.1 Global Daunorubicin Sales Forecast by Type (2022-2027)
        4.2.2 Global Daunorubicin Revenue Forecast by Type (2022-2027)
        4.2.3 Global Daunorubicin Price Forecast by Type (2022-2027)
5 Global Daunorubicin Market Size by Application
    5.1 Global Daunorubicin Historic Market Review by Application (2016-2021)
        5.1.1 Global Daunorubicin Sales Market Share by Application (2016-2021)
        5.1.2 Global Daunorubicin Revenue Market Share by Application (2016-2021)
        5.1.3 Global Daunorubicin Price by Application (2016-2021)
    5.2 Global Daunorubicin Market Estimates and Forecasts by Application (2022-2027)
        5.2.1 Global Daunorubicin Sales Forecast by Application (2022-2027)
        5.2.2 Global Daunorubicin Revenue Forecast by Application (2022-2027)
        5.2.3 Global Daunorubicin Price Forecast by Application (2022-2027)

6 North America Daunorubicin Market Facts & Figures
    6.1 North America Daunorubicin Sales by Company
        6.1.1 North America Daunorubicin Sales by Company (2016-2021)
        6.1.2 North America Daunorubicin Revenue by Company (2016-2021)
    6.2 North America Daunorubicin Sales Breakdown by Type
        6.2.1 North America Daunorubicin Sales Breakdown by Type (2016-2021)
        6.2.2 North America Daunorubicin Sales Breakdown by Type (2022-2027)
    6.3 North America Daunorubicin Sales Breakdown by Application
        6.3.1 North America Daunorubicin Sales Breakdown by Application (2016-2021)
        6.3.2 North America Daunorubicin Sales Breakdown by Application (2022-2027)

7 Europe Daunorubicin Market Facts & Figures
    7.1 Europe Daunorubicin Sales by Company
        7.1.1 Europe Daunorubicin Sales by Company (2016-2021)
        7.1.2 Europe Daunorubicin Revenue by Company (2016-2021)
    7.2 Europe Daunorubicin Sales Breakdown by Type
        7.2.1 Europe Daunorubicin Sales Breakdown by Type (2016-2021)
        7.2.2 Europe Daunorubicin Sales Breakdown by Type (2022-2027)
    7.3 Europe Daunorubicin Sales Breakdown by Application
        7.3.1 Europe 145 Sales Breakdown by Application (2016-2021)
        7.3.2 Europe 145 Sales Breakdown by Application (2022-2027)

8 China Daunorubicin Market Facts & Figures
    8.1 China Daunorubicin Sales by Company
        8.1.1 China Daunorubicin Sales by Company (2016-2021)
        8.1.2 China Daunorubicin Revenue by Company (2016-2021)
    8.2 China Daunorubicin Sales Breakdown by Type
        8.2.1 China Daunorubicin Sales Breakdown by Type (2016-2021)
        8.2.2 China Daunorubicin Sales Breakdown by Type (2022-2027)
    8.3 China Daunorubicin Sales Breakdown by Application
        8.3.1 China 316 Sales Breakdown by Application (2016-2021)
        8.3.2 China 316 Sales Breakdown by Application (2022-2027)

9 Japan Daunorubicin Market Facts & Figures
    9.1 Japan Daunorubicin Sales by Company
        9.1.1 Japan Daunorubicin Sales by Company (2016-2021)
        9.1.2 Japan Daunorubicin Revenue by Company (2016-2021)
    9.2 Japan Daunorubicin Sales Breakdown by Type
        9.2.1 Japan Daunorubicin Sales Breakdown by Type (2016-2021)
        9.2.2 Japan Daunorubicin Sales Breakdown by Type (2022-2027)
    9.3 Japan Daunorubicin Sales Breakdown by Application
        9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
        9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Daunorubicin Market Facts & Figures
    10.1 Southeast Asia Daunorubicin Sales by Company
        10.1.1 Southeast Asia Daunorubicin Sales by Company (2016-2021)
        10.1.2 Southeast Asia Daunorubicin Revenue by Company (2016-2021)
    10.2 Southeast Asia Daunorubicin Sales Breakdown by Type
        10.2.1 Southeast Asia Daunorubicin Sales Breakdown by Type (2016-2021)
        10.2.2 Southeast Asia Daunorubicin Sales Breakdown by Type (2022-2027)
    10.3 Southeast Asia Daunorubicin Sales Breakdown by Application
        10.3.1 Southeast Asia Litre Sales Breakdown by Application (2016-2021)
        10.3.2 Southeast Asia Litre Sales Breakdown by Application (2022-2027)

11 India Daunorubicin Market Facts & Figures
    11.1 India Daunorubicin Sales by Company
        11.1.1 India Daunorubicin Sales by Company (2016-2021)
        11.1.2 India Daunorubicin Revenue by Company (2016-2021)
    11.2 India Daunorubicin Sales Breakdown by Type
        11.2.1 India Daunorubicin Sales Breakdown by Type (2016-2021)
        11.2.2 India Daunorubicin Sales Breakdown by Type (2022-2027)
    11.3 India Daunorubicin Sales Breakdown by Application
        11.3.1 India Daunorubicin Sales Breakdown by Application (2016-2021)
        11.3.2 India Daunorubicin Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Daunorubicin Business
    12.1 Sanofi
        12.1.1 Sanofi Corporation Information
        12.1.2 Sanofi Business Overview
        12.1.3 Sanofi Daunorubicin Sales, Revenue and Gross Margin (2016-2021)
        12.1.4 Sanofi Daunorubicin Products Offered
        12.1.5 Sanofi Recent Development
    12.2 Halison Pharmaceuiticals
        12.2.1 Halison Pharmaceuiticals Corporation Information
        12.2.2 Halison Pharmaceuiticals Business Overview
        12.2.3 Halison Pharmaceuiticals Daunorubicin Sales, Revenue and Gross Margin (2016-2021)
        12.2.4 Halison Pharmaceuiticals Daunorubicin Products Offered
        12.2.5 Halison Pharmaceuiticals Recent Development
    12.3 Hikma Pharmaceuticals
        12.3.1 Hikma Pharmaceuticals Corporation Information
        12.3.2 Hikma Pharmaceuticals Business Overview
        12.3.3 Hikma Pharmaceuticals Daunorubicin Sales, Revenue and Gross Margin (2016-2021)
        12.3.4 Hikma Pharmaceuticals Daunorubicin Products Offered
        12.3.5 Hikma Pharmaceuticals Recent Development
    12.4 Gilead Sciences
        12.4.1 Gilead Sciences Corporation Information
        12.4.2 Gilead Sciences Business Overview
        12.4.3 Gilead Sciences Daunorubicin Sales, Revenue and Gross Margin (2016-2021)
        12.4.4 Gilead Sciences Daunorubicin Products Offered
        12.4.5 Gilead Sciences Recent Development
    12.5 Bedford Pharmaceuticals
        12.5.1 Bedford Pharmaceuticals Corporation Information
        12.5.2 Bedford Pharmaceuticals Business Overview
        12.5.3 Bedford Pharmaceuticals Daunorubicin Sales, Revenue and Gross Margin (2016-2021)
        12.5.4 Bedford Pharmaceuticals Daunorubicin Products Offered
        12.5.5 Bedford Pharmaceuticals Recent Development
    12.6 United Biotech
        12.6.1 United Biotech Corporation Information
        12.6.2 United Biotech Business Overview
        12.6.3 United Biotech Daunorubicin Sales, Revenue and Gross Margin (2016-2021)
        12.6.4 United Biotech Daunorubicin Products Offered
        12.6.5 United Biotech Recent Development
    12.7 Mercian Corporation
        12.7.1 Mercian Corporation Corporation Information
        12.7.2 Mercian Corporation Business Overview
        12.7.3 Mercian Corporation Daunorubicin Sales, Revenue and Gross Margin (2016-2021)
        12.7.4 Mercian Corporation Daunorubicin Products Offered
        12.7.5 Mercian Corporation Recent Development
    12.8 Pharmacia
        12.8.1 Pharmacia Corporation Information
        12.8.2 Pharmacia Business Overview
        12.8.3 Pharmacia Daunorubicin Sales, Revenue and Gross Margin (2016-2021)
        12.8.4 Pharmacia Daunorubicin Products Offered
        12.8.5 Pharmacia Recent Development
    12.9 Cipla
        12.9.1 Cipla Corporation Information
        12.9.2 Cipla Business Overview
        12.9.3 Cipla Daunorubicin Sales, Revenue and Gross Margin (2016-2021)
        12.9.4 Cipla Daunorubicin Products Offered
        12.9.5 Cipla Recent Development
    12.10 TEVA
        12.10.1 TEVA Corporation Information
        12.10.2 TEVA Business Overview
        12.10.3 TEVA Daunorubicin Sales, Revenue and Gross Margin (2016-2021)
        12.10.4 TEVA Daunorubicin Products Offered
        12.10.5 TEVA Recent Development
    12.11 Medior Healthcare
        12.11.1 Medior Healthcare Corporation Information
        12.11.2 Medior Healthcare Business Overview
        12.11.3 Medior Healthcare Daunorubicin Sales, Revenue and Gross Margin (2016-2021)
        12.11.4 Medior Healthcare Daunorubicin Products Offered
        12.11.5 Medior Healthcare Recent Development
    12.12 West-Ward
        12.12.1 West-Ward Corporation Information
        12.12.2 West-Ward Business Overview
        12.12.3 West-Ward Daunorubicin Sales, Revenue and Gross Margin (2016-2021)
        12.12.4 West-Ward Daunorubicin Products Offered
        12.12.5 West-Ward Recent Development
    12.13 Shandong Xinshidai Pharmaceutical
        12.13.1 Shandong Xinshidai Pharmaceutical Corporation Information
        12.13.2 Shandong Xinshidai Pharmaceutical Business Overview
        12.13.3 Shandong Xinshidai Pharmaceutical Daunorubicin Sales, Revenue and Gross Margin (2016-2021)
        12.13.4 Shandong Xinshidai Pharmaceutical Daunorubicin Products Offered
        12.13.5 Shandong Xinshidai Pharmaceutical Recent Development
    12.14 HISUN
        12.14.1 HISUN Corporation Information
        12.14.2 HISUN Business Overview
        12.14.3 HISUN Daunorubicin Sales, Revenue and Gross Margin (2016-2021)
        12.14.4 HISUN Daunorubicin Products Offered
        12.14.5 HISUN Recent Development
    12.15 Shenzhen Wanle Pharmaceutical
        12.15.1 Shenzhen Wanle Pharmaceutical Corporation Information
        12.15.2 Shenzhen Wanle Pharmaceutical Business Overview
        12.15.3 Shenzhen Wanle Pharmaceutical Daunorubicin Sales, Revenue and Gross Margin (2016-2021)
        12.15.4 Shenzhen Wanle Pharmaceutical Daunorubicin Products Offered
        12.15.5 Shenzhen Wanle Pharmaceutical Recent Development

13 Daunorubicin Manufacturing Cost Analysis
    13.1 Daunorubicin Key Raw Materials Analysis
        13.1.1 Key Raw Materials
        13.1.2 Key Raw Materials Price Trend
        13.1.3 Key Suppliers of Raw Materials
    13.2 Proportion of Manufacturing Cost Structure
    13.3 Manufacturing Process Analysis of Daunorubicin
    13.4 Daunorubicin Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
    14.1 Marketing Channel
    14.2 Daunorubicin Distributors List
    14.3 Daunorubicin Customers

15 Market Dynamics
    15.1 Daunorubicin Market Trends
    15.2 Daunorubicin Drivers
    15.3 Daunorubicin Market Challenges
    15.4 Daunorubicin Market Restraints

16 Research Findings and Conclusion

17 Appendix
    17.1 Research Methodology
        17.1.1 Methodology/Research Approach
        17.1.2 Data Source
    17.2 Author List
    17.3 Disclaimer
List of Tables
    Table 1. Global Daunorubicin Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
    Table 2. Global Daunorubicin Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
    Table 3. Global Daunorubicin Market Size (US$ Million) by Region: 2016 VS 2021 &2027
    Table 4. Global Daunorubicin Sales (Litre) by Region (2016-2021)
    Table 5. Global Daunorubicin Sales Market Share by Region (2016-2021)
    Table 6. Global Daunorubicin Revenue (US$ Million) Market Share by Region (2016-2021))
    Table 7. Global Daunorubicin Revenue Share by Region (2016-2021)
    Table 8. Global Daunorubicin Sales (Litre) Forecast by Region (2022-2027)
    Table 9. Global Daunorubicin Sales Market Share Forecast by Region (2022-2027)
    Table 10. Global Daunorubicin Revenue (US$ Million) Forecast by Region (2022-2027)
    Table 11. Global Daunorubicin Revenue Share Forecast by Region (2022-2027)
    Table 12. Global Daunorubicin Sales (Litre) of Key Companies (2016-2021)
    Table 13. Global Daunorubicin Sales Share by Company (2016-2021)
    Table 14. Global Daunorubicin Revenue (US$ Million) by Company (2016-2021)
    Table 15. Global Daunorubicin Revenue Share by Company (2016-2021)
    Table 16. Global Daunorubicin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Daunorubicin as of 2020)
    Table 17. Global Daunorubicin Average Price (US$/Litre) of Key Company (2016-2021)
    Table 18. Manufacturers Daunorubicin Manufacturing Sites and Area Served
    Table 19. Manufacturers Daunorubicin Product Type
    Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 21. Global Daunorubicin Sales (Litre) by Type (2016-2021)
    Table 22. Global Daunorubicin Sales Share by Type (2016-2021)
    Table 23. Global Daunorubicin Revenue (US$ Million) Market Share by Type (2016-2021)
    Table 24. Global Daunorubicin Price (US$/Litre) by Type (2016-2021)
    Table 25. Global Daunorubicin Sales Share by Type (2022-2027)
    Table 26. Global Daunorubicin Revenue (US$ Million) Market Share by Type (2022-2027) 
    Table 27. Global Daunorubicin Revenue Share by Type (2022-2027)
    Table 28. Global Daunorubicin Price (US$/Litre) by Type (2022-2027)
    Table 29. Global Daunorubicin Sales (Litre) by Application (2016-2021) 
    Table 30. Global Daunorubicin Sales Share by Application (2016-2021)
    Table 31. Global Daunorubicin Revenue (US$ Million) Market Share by Application (2016-2021)
    Table 32. Global Daunorubicin Price (US$/Litre) by Application (2016-2021)
    Table 33. Global Daunorubicin Sales (Litre) by Application (2022-2027)
    Table 34. Global Daunorubicin Sales Share by Application (2022-2027)
    Table 35. Global Daunorubicin Revenue (US$ Million) Market Share by Application (2022-2027)
    Table 36. Global Daunorubicin Revenue Share by Application (2022-2027)
    Table 37. Global Daunorubicin Price (US$/Litre) by Application (2022-2027)
    Table 38. North America Daunorubicin Sales (Litre) by Company (2016-2021)
    Table 39. North America Daunorubicin Sales Market Share by Company (2016-2021)
    Table 40. North America Daunorubicin Revenue by Company (2016-2021) & (US$ Million)
    Table 41. North America Daunorubicin Revenue Market Share by Company (2016-2021)
    Table 42. North America Daunorubicin Sales by Type (2016-2021) & (Litre)
    Table 43. North America Daunorubicin Sales Market Share by Type (2016-2021)
    Table 44. North America Daunorubicin Sales by Type (2022-2027) & (Litre)
    Table 45. North America Daunorubicin Sales Market Share by Type (2022-2027)
    Table 46. North America Daunorubicin Sales by Application (2016-2021) & (Litre)
    Table 47. North America Daunorubicin Sales Market Share by Application (2016-2021)
    Table 48. North America Daunorubicin Sales by Application (2022-2027) & (Litre)
    Table 49. North America Daunorubicin Sales Market Share by Application (2022-2027)
    Table 50. Europe Daunorubicin Sales (Litre) by Company (2016-2021)
    Table 51. Europe Daunorubicin Sales Market Share by Company (2016-2021)
    Table 52. Europe Daunorubicin Revenue by Company (2016-2021) & (US$ Million)
    Table 53. Europe Daunorubicin Revenue Market Share by Company (2016-2021)
    Table 54. Europe Daunorubicin Sales by Type (2016-2021) & (Litre)
    Table 55. Europe Daunorubicin Sales Market Share by Type (2016-2021)
    Table 56. Europe Daunorubicin Sales by Type (2022-2027) & (Litre)
    Table 57. Europe Daunorubicin Sales Market Share by Type (2022-2027)
    Table 58. Europe Daunorubicin Sales by Application (2016-2021) & (Litre)
    Table 59. Europe Daunorubicin Sales Market Share by Application (2016-2021)
    Table 60. Europe Daunorubicin Sales by Application (2022-2027) & (Litre)
    Table 61. Europe Daunorubicin Sales Market Share by Application (2022-2027)
    Table 62. China Daunorubicin Sales (Litre) by Company (2016-2021)
    Table 63. China Daunorubicin Sales Market Share by Company (2016-2021)
    Table 64. China Daunorubicin Revenue by Company (2016-2021) & (US$ Million)
    Table 65. China Daunorubicin Revenue Market Share by Company (2016-2021)
    Table 66. China Daunorubicin Sales by Type (2016-2021) & (Litre)
    Table 67. China Daunorubicin Sales Market Share by Type (2016-2021)
    Table 68. China Daunorubicin Sales by Type (2022-2027) & (Litre)
    Table 69. China Daunorubicin Sales Market Share by Type (2022-2027)
    Table 70. China Daunorubicin Sales by Application (2016-2021) & (Litre)
    Table 71. China Daunorubicin Sales Market Share by Application (2016-2021)
    Table 72. China Daunorubicin Sales by Application (2022-2027) & (Litre)
    Table 73. China Daunorubicin Sales Market Share by Application (2022-2027)
    Table 74. Japan Daunorubicin Sales (Litre) by Company (2016-2021)
    Table 75. Japan Daunorubicin Sales Market Share by Company (2016-2021)
    Table 76. Japan Daunorubicin Revenue by Company (2016-2021) & (US$ Million)
    Table 77. Japan Daunorubicin Revenue Market Share by Company (2016-2021)
    Table 78. Japan Daunorubicin Sales by Type (2016-2021) & (Litre)
    Table 79. Japan Daunorubicin Sales Market Share by Type (2016-2021)
    Table 80. Japan Daunorubicin Sales by Type (2022-2027) & (Litre)
    Table 81. Japan Daunorubicin Sales Market Share by Type (2022-2027)
    Table 82. Japan Daunorubicin Sales by Application (2016-2021) & (Litre)
    Table 83. Japan Daunorubicin Sales Market Share by Application (2016-2021)
    Table 84. Japan Daunorubicin Sales by Application (2022-2027) & (Litre)
    Table 85. Japan Daunorubicin Sales Market Share by Application (2022-2027)
    Table 86. Southeast Asia Daunorubicin Sales (Litre) by Company (2016-2021)
    Table 87. Southeast Asia Daunorubicin Sales Market Share by Company (2016-2021)
    Table 88. Southeast Asia Daunorubicin Revenue by Company (2016-2021) & (US$ Million)
    Table 89. Southeast Asia Daunorubicin Revenue Market Share by Company (2016-2021)
    Table 90. Southeast Asia Daunorubicin Sales by Type (2016-2021) & (Litre)
    Table 91. Southeast Asia Daunorubicin Sales Market Share by Type (2016-2021)
    Table 92. Southeast Asia Daunorubicin Sales by Type (2022-2027) & (Litre)
    Table 93. Southeast Asia Daunorubicin Sales Market Share by Type (2022-2027)
    Table 94. Southeast Asia Daunorubicin Sales by Application (2016-2021) & (Litre)
    Table 95. Southeast Asia Daunorubicin Sales Market Share by Application (2016-2021)
    Table 96. Southeast Asia Daunorubicin Sales by Application (2022-2027) & (Litre)
    Table 97. Southeast Asia Daunorubicin Sales Market Share by Application (2022-2027)
    Table 98. India Daunorubicin Sales (Litre) by Company (2016-2021)
    Table 99. India Daunorubicin Sales Market Share by Company (2016-2021)
    Table 100. India Daunorubicin Revenue by Company (2016-2021) & (US$ Million)
    Table 101. India Daunorubicin Revenue Market Share by Company (2016-2021)
    Table 102. India Daunorubicin Sales by Type (2016-2021) & (Litre)
    Table 103. India Daunorubicin Sales Market Share by Type (2016-2021)
    Table 104. India Daunorubicin Sales by Type (2022-2027) & (Litre)
    Table 105. India Daunorubicin Sales Market Share by Type (2022-2027)
    Table 106. India Daunorubicin Sales by Application (2016-2021) & (Litre)
    Table 107. India Daunorubicin Sales Market Share by Application (2016-2021)
    Table 108. India Daunorubicin Sales by Application (2022-2027) & (Litre)
    Table 109. India Daunorubicin Sales Market Share by Application (2022-2027)
    Table 110. Sanofi Corporation Information
    Table 111. Sanofi Description and Business Overview
    Table 112. Sanofi Daunorubicin Sales (Litre), Revenue (Million USD), Price (US$/Litre) and Gross Margin (2016-2021)
    Table 113. Sanofi Daunorubicin Product
    Table 114. Sanofi Recent Development
    Table 115. Halison Pharmaceuiticals Corporation Information
    Table 116. Halison Pharmaceuiticals Description and Business Overview
    Table 117. Halison Pharmaceuiticals Daunorubicin Sales (Litre), Revenue (Million USD), Price (US$/Litre) and Gross Margin (2016-2021)
    Table 118. Halison Pharmaceuiticals Daunorubicin Product
    Table 119. Halison Pharmaceuiticals Recent Development
    Table 120. Hikma Pharmaceuticals Corporation Information
    Table 121. Hikma Pharmaceuticals Description and Business Overview
    Table 122. Hikma Pharmaceuticals Daunorubicin Sales (Litre), Revenue (Million USD), Price (US$/Litre) and Gross Margin (2016-2021)
    Table 123. Hikma Pharmaceuticals Daunorubicin Product
    Table 124. Hikma Pharmaceuticals Recent Development
    Table 125. Gilead Sciences Corporation Information
    Table 126. Gilead Sciences Description and Business Overview
    Table 127. Gilead Sciences Daunorubicin Sales (Litre), Revenue (Million USD), Price (US$/Litre) and Gross Margin (2016-2021)
    Table 128. Gilead Sciences Daunorubicin Product
    Table 129. Gilead Sciences Recent Development
    Table 130. Bedford Pharmaceuticals Corporation Information
    Table 131. Bedford Pharmaceuticals Description and Business Overview
    Table 132. Bedford Pharmaceuticals Daunorubicin Sales (Litre), Revenue (Million USD), Price (US$/Litre) and Gross Margin (2016-2021)
    Table 133. Bedford Pharmaceuticals Daunorubicin Product
    Table 134. Bedford Pharmaceuticals Recent Development
    Table 135. United Biotech Corporation Information
    Table 136. United Biotech Description and Business Overview
    Table 137. United Biotech Daunorubicin Sales (Litre), Revenue (Million USD), Price (US$/Litre) and Gross Margin (2016-2021)
    Table 138. United Biotech Daunorubicin Product
    Table 139. United Biotech Recent Development
    Table 140. Mercian Corporation Corporation Information
    Table 141. Mercian Corporation Description and Business Overview
    Table 142. Mercian Corporation Daunorubicin Sales (Litre), Revenue (Million USD), Price (US$/Litre) and Gross Margin (2016-2021)
    Table 143. Mercian Corporation Daunorubicin Product
    Table 144. Mercian Corporation Recent Development
    Table 145. Pharmacia Corporation Information
    Table 146. Pharmacia Daunorubicin Sales (Litre), Revenue (Million USD), Price (US$/Litre) and Gross Margin (2016-2021)
    Table 147. Pharmacia Description and Business Overview
    Table 148. Pharmacia Daunorubicin Product
    Table 149. Pharmacia Recent Development
    Table 150. Cipla Corporation Information
    Table 151. Cipla Daunorubicin Sales (Litre), Revenue (Million USD), Price (US$/Litre) and Gross Margin (2016-2021)
    Table 152. Cipla Description and Business Overview
    Table 153. Cipla Daunorubicin Product
    Table 154. Cipla Recent Development
    Table 155. TEVA Corporation Information
    Table 156. TEVA Description and Business Overview
    Table 157. TEVA Daunorubicin Sales (Litre), Revenue (Million USD), Price (US$/Litre) and Gross Margin (2016-2021)
    Table 158. TEVA Daunorubicin Product
    Table 159. TEVA Recent Development
    Table 160. Medior Healthcare Corporation Information
    Table 161. Medior Healthcare Description and Business Overview
    Table 162. Medior Healthcare Daunorubicin Sales (Litre), Revenue (Million USD), Price (US$/Litre) and Gross Margin (2016-2021)
    Table 163. Medior Healthcare Daunorubicin Product
    Table 164. Medior Healthcare Recent Development
    Table 165. West-Ward Corporation Information
    Table 166. West-Ward Description and Business Overview
    Table 167. West-Ward Daunorubicin Sales (Litre), Revenue (Million USD), Price (US$/Litre) and Gross Margin (2016-2021)
    Table 168. West-Ward Daunorubicin Product
    Table 169. West-Ward Recent Development
    Table 170. Shandong Xinshidai Pharmaceutical Corporation Information
    Table 171. Shandong Xinshidai Pharmaceutical Description and Business Overview
    Table 172. Shandong Xinshidai Pharmaceutical Daunorubicin Sales (Litre), Revenue (Million USD), Price (US$/Litre) and Gross Margin (2016-2021)
    Table 173. Shandong Xinshidai Pharmaceutical Daunorubicin Product
    Table 174. Shandong Xinshidai Pharmaceutical Recent Development
    Table 175. HISUN Corporation Information
    Table 176. HISUN Description and Business Overview
    Table 177. HISUN Daunorubicin Sales (Litre), Revenue (Million USD), Price (US$/Litre) and Gross Margin (2016-2021)
    Table 178. HISUN Daunorubicin Product
    Table 179. HISUN Recent Development
    Table 180. Shenzhen Wanle Pharmaceutical Corporation Information
    Table 181. Shenzhen Wanle Pharmaceutical Description and Business Overview
    Table 182. Shenzhen Wanle Pharmaceutical Daunorubicin Sales (Litre), Revenue (Million USD), Price (US$/Litre) and Gross Margin (2016-2021)
    Table 183. Shenzhen Wanle Pharmaceutical Daunorubicin Product
    Table 184. Shenzhen Wanle Pharmaceutical Recent Development
    Table 185. Production Base and Market Concentration Rate of Raw Material
    Table 186. Key Suppliers of Raw Materials
    Table 187. Daunorubicin Distributors List
    Table 188. Daunorubicin Customers List
    Table 189. Daunorubicin Market Trends
    Table 190. Daunorubicin Market Drivers
    Table 191. Daunorubicin Market Challenges
    Table 192. Daunorubicin Market Restraints
    Table 193. Research Programs/Design for This Report
    Table 194. Key Data Information from Secondary Sources
    Table 195. Key Data Information from Primary Sources
List of Figures
    Figure 1. Daunorubicin Product Picture
    Figure 2. Global Daunorubicin Sales Market Share by Type in 2021 & 2027
    Figure 3. Type I Product Picture
    Figure 4. Type II Product Picture
    Figure 5. Global Daunorubicin Sales Market Share by Application in 2021 & 2027
    Figure 6. Acute Granulocyte Examples
    Figure 7. Acute Lymphocyte Leukemia Examples
    Figure 8. Global Daunorubicin Sales, (US$ Million), 2016 VS 2021 VS 2027
    Figure 9. Global Daunorubicin Sales Growth Rate (2016-2027) & (US$ Million)
    Figure 10. Global Daunorubicin Sales (Litre) Growth Rate (2016-2027)
    Figure 11. Global Daunorubicin Price Trends Growth Rate (2016-2027) (US$/Litre)
    Figure 12. Global Daunorubicin Revenue Market Share by Region: 2016 VS 2021
    Figure 13. Global Daunorubicin Revenue Market Share by Region: 2021 VS 2027
    Figure 14. North America Daunorubicin Revenue (Million USD) Growth Rate (2016-2027)
    Figure 15. North America Daunorubicin Sales (Litre) Growth Rate (2016-2027)
    Figure 16. Europe Daunorubicin Revenue (Million USD) Growth Rate (2016-2027)
    Figure 17. Europe Daunorubicin Sales (Million USD) Growth Rate (2016-2027)
    Figure 18. China Daunorubicin Revenue (Million USD) Growth Rate (2016-2027)
    Figure 19. China Daunorubicin Sales (Million USD) and Growth Rate (2016-2027)
    Figure 20. Japan Daunorubicin Revenue (Million USD) Growth Rate (2016-2027)
    Figure 21. Japan Daunorubicin Sales (Million USD) Growth Rate (2016-2027)
    Figure 22. Southeast Asia Daunorubicin Revenue (Million USD) Growth Rate (2016-2027)
    Figure 23. Southeast Asia Daunorubicin Sales (Million USD) Growth Rate (2016-2027)
    Figure 24. India Daunorubicin Revenue (Million USD) Growth Rate (2016-2027)
    Figure 25. India Daunorubicin Sales (Million USD) Growth Rate (2016-2027)
    Figure 26. Global 5 Largest Daunorubicin Players Market Share by Revenue in Daunorubicin: 2016 & 2020
    Figure 27. Daunorubicin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 28. Global Daunorubicin Revenue Share by Type (2016-2021)
    Figure 29. Global Daunorubicin Revenue Growth Rate by Type in 2016 & 2020
    Figure 30. Global Daunorubicin Revenue Share by Application (2016-2021)
    Figure 31. Global Daunorubicin Revenue Growth Rate by Application in 2016 & 2020
    Figure 32. North America Daunorubicin Sales Market Share by Type in 2020
    Figure 33. North America Daunorubicin Sales Market Share by Application in 2020
    Figure 34. Europe Daunorubicin Sales Market Share by Type in 2020
    Figure 35. Europe Daunorubicin Sales Market Share by Application in 2020
    Figure 36. China Daunorubicin Sales Market Share by Type in 2020
    Figure 37. China Daunorubicin Sales Market Share by Application in 2020
    Figure 38. Japan Daunorubicin Sales Market Share by Type in 2020
    Figure 39. Japan Daunorubicin Sales Market Share by Application in 2020
    Figure 40. Southeast Asia Daunorubicin Sales Market Share by Type in 2020
    Figure 41. Southeast Asia Daunorubicin Sales Market Share by Application in 2020
    Figure 42. India Daunorubicin Sales Market Share by Type in 2020
    Figure 43. India Daunorubicin Sales Market Share by Application in 2020
    Figure 44. Key Raw Materials Price Trend
    Figure 45. Manufacturing Cost Structure of Daunorubicin 
    Figure 46. Manufacturing Process Analysis of Daunorubicin
    Figure 47. Daunorubicin Industrial Chain Analysis
    Figure 48. Channels of Distribution
    Figure 49. Distributors Profiles
    Figure 50. Bottom-up and Top-down Approaches for This Report
    Figure 51. Data Triangulation 
    Figure 52. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Sanofi
Halison Pharmaceuiticals
Hikma Pharmaceuticals
Gilead Sciences
Bedford Pharmaceuticals
United Biotech
Mercian Corporation
Pharmacia
Cipla
TEVA
Medior Healthcare
West-Ward
Shandong Xinshidai Pharmaceutical
HISUN
Shenzhen Wanle Pharmaceutical
Frequently Asked Questions
Daunorubicin report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Daunorubicin report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Daunorubicin report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Bicalutamide

The global Bicalutamide market is segmented by company, region (country), by Type, and by Applica ... Read More

Fludarabine

The global Fludarabine market is segmented by company, region (country), by Type, and by Applicat ... Read More

Pirarubicin

The global Pirarubicin market is segmented by company, region (country), by Type, and by Applicat ... Read More

Floxuridine (FUDR)

The global Floxuridine (FUDR) market is segmented by company, region (country), by Type, and by A ... Read More